Setchenska M S, Arnstein H R
Biochem J. 1983 Feb 15;210(2):559-66. doi: 10.1042/bj2100559.
After fractionation of rabbit bone marrow into dividing (early) and non-dividing (late) erythroid cells, the adenylate cyclase activity of membrane ghosts was assayed in the presence of guanine nucleotides ((GTP and its analogue p[NH]ppG (guanosine 5'-[beta, gamma-imido]triphosphate))), the beta-adrenergic agonist L-isoprenaline (L-isoproterenol) and the antagonist L-propranolol. Both GTP and p[NH]ppG increased the adenylate cyclase activity of early and late erythroblasts, whereas the stimulating effect of the beta-adrenergic drug L-isoprenaline was limited to the immature dividing bone-marrow cells. The effect of L-isoprenaline was completely inhibited by the antagonist L-propranolol, confirming that the response was due to stimulation of beta-adrenergic receptors on the plasma membrane. The lack of response of non-dividing erythroblasts to beta-adrenergic stimuli is not due to loss of beta-receptors, since both dividing and non-dividing cells bind the selective ligand [125I]iodohydroxybenzylpindolol with almost equal affinities, the apparent dissociation constants, Kd, being 0.91 X 10(-8)M and 1.0 X 10(-8) M respectively. The number of beta-adrenergic receptors per cell was 2-fold higher in the dividing cells. No significant change in binding affinity for GTP and p[NH]ppG during erythroblast development was observed: the dissociation constants of both guanine nucleotides were almost identical with early and late erythroblast membrane preparations [2-3 (X 10(-7) M]. With dividing cells, however, in the presence of L-isoprenaline the dissociation constants of GTP and p[NH]ppG were lower (6 X 10(-8) M). The dose-response curves for isoprenaline competition in binding of [125I]iodohydroxybenzylpindolol by dividing cells showed that the EC50 (effective concentration for half maximum activity) value for isoprenaline was higher in the presence of p[NH]ppG. With non-dividing cells the EC50 value for isoprenaline was equal in the presence and in the absence of p[NH]ppG and similar to that observed with dividing-cell membranes in the presence of the nucleotide. Thus differentiation of rabbit bone-marrow erythroid cells seems to be accompanied by uncoupling of the beta-adrenergic receptors from the adenylate cyclase catalytic protein as well as by a decrease in the number of receptors per cell, but not by changes in the catecholamine and guanine-nucleotide-binding affinities.
将兔骨髓细胞分离为增殖期(早期)和非增殖期(晚期)红细胞后,在鸟嘌呤核苷酸(GTP及其类似物p[NH]ppG(鸟苷5'-[β,γ-亚氨基]三磷酸))、β-肾上腺素能激动剂L-异丙肾上腺素(L-异丙去甲肾上腺素)和拮抗剂L-普萘洛尔存在的情况下,检测膜微粒体的腺苷酸环化酶活性。GTP和p[NH]ppG均增加早期和晚期成红细胞的腺苷酸环化酶活性,而β-肾上腺素能药物L-异丙肾上腺素的刺激作用仅限于未成熟的增殖骨髓细胞。拮抗剂L-普萘洛尔完全抑制了L-异丙肾上腺素的作用,证实该反应是由于质膜上β-肾上腺素能受体受到刺激。非增殖期成红细胞对β-肾上腺素能刺激无反应并非由于β-受体丧失,因为增殖期和非增殖期细胞与选择性配体[125I]碘羟基苄基吲哚洛尔的结合亲和力几乎相等,表观解离常数Kd分别为0.91×10⁻⁸M和1.0×10⁻⁸M。每个细胞的β-肾上腺素能受体数量在增殖期细胞中高出2倍。在成红细胞发育过程中,未观察到对GTP和p[NH]ppG的结合亲和力有显著变化:两种鸟嘌呤核苷酸与早期和晚期成红细胞膜制剂的解离常数几乎相同[2 - 3(×10⁻⁷M)]。然而,对于增殖期细胞,在L-异丙肾上腺素存在的情况下,GTP和p[NH]ppG的解离常数较低(6×10⁻⁸M)。增殖期细胞中L-异丙肾上腺素竞争结合[125I]碘羟基苄基吲哚洛尔的剂量反应曲线表明,在p[NH]ppG存在的情况下,L-异丙肾上腺素的EC50(最大活性一半时的有效浓度)值较高。对于非增殖期细胞,在p[NH]ppG存在和不存在的情况下,L-异丙肾上腺素的EC50值相等,且与在核苷酸存在情况下增殖期细胞膜的观察值相似。因此,兔骨髓红细胞的分化似乎伴随着β-肾上腺素能受体与腺苷酸环化酶催化蛋白的解偶联以及每个细胞受体数量的减少,但儿茶酚胺和鸟嘌呤核苷酸结合亲和力没有变化。